-
Speaking at the ‘Innovative Chemistry for Peptide Manufacturing and Analysis’ conference, SB3000’s Chief R&D Officer Jens Bukrinski revealed that continuous manufacturing μLOT® technology could reduce the pharmaceutical industry’s use of toxic chemicals by 100 times.
Mar 23, 2021
-
Mar 23, 2021
-
Mar 24, 2021
-
SignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, has announced a collaboration with Merck, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA®, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).
Mar 24, 2021
-
RegDesk, a regulatory approval software company, has released an updated version of its 'Dash' platform for device manufacturers.
Mar 24, 2021
-
Mar 25, 2021
-
Mar 28, 2021
-
Mar 28, 2021
-
Albumedix Ltd., an enabler of advanced therapies and world leader in recombinant human albumin, has announced a new distribution partnership with FUJIFILM Wako Pure Chemical Corporation (FUJIFILM Wako), to advance therapy and biopharmaceutical development in Japan and China including Hong Kong.
Mar 28, 2021
-
Mar 29, 2021
-
ENPICOM BV, an innovative bioinformatics software engineering company, has announced the approval of a joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application with Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development.
Mar 29, 2021
-
Panthera is enrolling Covid patients for AstraZeneca’s monoclonal antibody study to reduce disease severity.
Mar 30, 2021
-
VERICHEM LABORATORIES now offers medical laboratory professionals an extensive array of liquid stable, protein based, ready-to-use clinical reference material for Total and Direct Bilirubin assays for CLIA compliance.
Apr 1, 2021
-
Repositive has today announced that Vivan Therapeutics, an innovative personalised therapeutics company, will be the next company to join its global network of cancer model partners. Vivan Therapeutics has unique experience in engineering drosophila ‘avatar’ models for cancer research and development unique experience in engineering drosophila ‘avatar’ models for cancer research and development
Mar 1, 2021
-
Mar 2, 2021
-
108Labs announces Colostrupedics™ whole-human infant formula, made possible with the discovery of novel secretory antibody biosynthesis. This is the first animal-free infant formula that exclusively comprises cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.
Mar 7, 2021
-
VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.
Mar 7, 2021
-
Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates, has signed a licensing agreement with La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system, to develop novel COVID-19 diagnostics tools.
Mar 8, 2021
-
PCR Biosystems have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Without the need for high temperature denaturation or specialised thermocycling equipment, IsoFast™ Bst Polymerase enables faster results and can be used in the field. This makes it ideal for a range of applications including environmental and food pathogen testing and clinical diagnostics – including for qualitative detection of the SARS-CoV-2 nucleic acid.
Mar 9, 2021
-
Mar 3, 2021